GD SEARLE LLC
Big PharmaGD SEARLE LLC is a major pharmaceutical company focused on Immunology.
GD SEARLE LLC's Key Drugs
GD SEARLE LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
GD SEARLE LLC's Recent FDA Approvals
New NDA/BLA approvals for GD SEARLE LLC over the last two years — novel drugs only, excluding generics and label supplements.
GD SEARLE LLC's Therapeutic Areas
GD SEARLE LLC's approved drugs and pipeline span 1 therapeutic area, led by Immunology, across 0 biologic and 3 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
GD SEARLE LLC's Top Competitors
GD SEARLE LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
GD SEARLE LLC Pipeline Snapshot
Active clinical trials for GD SEARLE LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1940-04-19
- Latest
- 2022-04-29
- Applications
- 30